Search research articles
Contact Us
Filters
Showing results (51-60 of 77) with videos related to
Page
of 8
Sort By:
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration
|
February 24, 2024
The ALSFRS-R Summit: a global call to action on the use of the ALSFRS-R in ALS clinical trials
Angela Genge, Jesse M Cedarbaum, Jeremy Shefner, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration
|
July 9, 2019
Masitinib as an add-on therapy to riluzole in patients with amyotrophic lateral sclerosis: a randomized clinical trial
Jesus S Mora, Angela Genge, Adriano Chio, et al.
Nature Communications
|
August 17, 2023
Randomized, double-blind, placebo-controlled trial of rapamycin in amyotrophic lateral sclerosis
Jessica Mandrioli, Roberto D'Amico, Elisabetta Zucchi, et al.
Neurology
|
March 10, 2019
Revised Airlie House consensus guidelines for design and implementation of ALS clinical trials
Leonard H van den Berg, Eric Sorenson, Gary Gronseth, et al.
Journal of Neurology
|
August 16, 2015
C9ORF72 intermediate repeat expansion in patients affected by atypical parkinsonian syndromes or Parkinson's disease complicated by psychosis or dementia in a Sardinian population
Antonino Cannas, Paolo Solla, Giuseppe Borghero, et al.
Neurology
|
October 6, 2017
Meta-analysis of pharmacogenetic interactions in amyotrophic lateral sclerosis clinical trials
Ruben P A van Eijk, Ashley R Jones, William Sproviero, et al.
Brain Communications
|
October 28, 2021
<i>SCFD1</i> expression quantitative trait loci in amyotrophic lateral sclerosis are differentially expressed
Alfredo Iacoangeli, Isabella Fogh, Sashika Selvackadunco, et al.
The Lancet. Neurology
|
October 11, 2014
Analysis of amyotrophic lateral sclerosis as a multistep process: a population-based modelling study
Ammar Al-Chalabi, Andrea Calvo, Adriano Chio, et al.
JAMA Neurology
|
March 24, 2025
Reldesemtiv in Amyotrophic Lateral Sclerosis: Results From the COURAGE-ALS Randomized Clinical Trial
Jeremy M Shefner, Merit E Cudkowicz, Angela Genge, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration
|
June 12, 2025
Hospitalizations as an outcome measure in COURAGE-ALS
Stacy A Rudnicki, Ammar Al-Chalabi, Jinsy A Andrews, et al.
Page
of 8
Search research articles
Search
Showing results (51-60 of 77) with videos related to
Sort By:
Page
of 8
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration
|
February 24, 2024
The ALSFRS-R Summit: a global call to action on the use of the ALSFRS-R in ALS clinical trials
Angela Genge, Jesse M Cedarbaum, Jeremy Shefner, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration
|
July 9, 2019
Masitinib as an add-on therapy to riluzole in patients with amyotrophic lateral sclerosis: a randomized clinical trial
Jesus S Mora, Angela Genge, Adriano Chio, et al.
Nature Communications
|
August 17, 2023
Randomized, double-blind, placebo-controlled trial of rapamycin in amyotrophic lateral sclerosis
Jessica Mandrioli, Roberto D'Amico, Elisabetta Zucchi, et al.
Neurology
|
March 10, 2019
Revised Airlie House consensus guidelines for design and implementation of ALS clinical trials
Leonard H van den Berg, Eric Sorenson, Gary Gronseth, et al.
Journal of Neurology
|
August 16, 2015
C9ORF72 intermediate repeat expansion in patients affected by atypical parkinsonian syndromes or Parkinson's disease complicated by psychosis or dementia in a Sardinian population
Antonino Cannas, Paolo Solla, Giuseppe Borghero, et al.
Neurology
|
October 6, 2017
Meta-analysis of pharmacogenetic interactions in amyotrophic lateral sclerosis clinical trials
Ruben P A van Eijk, Ashley R Jones, William Sproviero, et al.
Brain Communications
|
October 28, 2021
<i>SCFD1</i> expression quantitative trait loci in amyotrophic lateral sclerosis are differentially expressed
Alfredo Iacoangeli, Isabella Fogh, Sashika Selvackadunco, et al.
The Lancet. Neurology
|
October 11, 2014
Analysis of amyotrophic lateral sclerosis as a multistep process: a population-based modelling study
Ammar Al-Chalabi, Andrea Calvo, Adriano Chio, et al.
JAMA Neurology
|
March 24, 2025
Reldesemtiv in Amyotrophic Lateral Sclerosis: Results From the COURAGE-ALS Randomized Clinical Trial
Jeremy M Shefner, Merit E Cudkowicz, Angela Genge, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration
|
June 12, 2025
Hospitalizations as an outcome measure in COURAGE-ALS
Stacy A Rudnicki, Ammar Al-Chalabi, Jinsy A Andrews, et al.
Page
of 8